ArticleHeliyon2023

FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma.

Min Xun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.